戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                   There was no evidence of a pharmacokinetic interaction.
2 itaxel dose is reduced to compensate for the pharmacokinetic interaction.
3 st likely related to P450, contribute to the pharmacokinetic interaction.
4 ersal in cancer treatment and drug-flavonoid pharmacokinetic interactions.
5 ose of the combination regimen and to assess pharmacokinetic interactions.
6 rotein cholesterol-occurred independently of pharmacokinetic interactions.
7                                There were no pharmacokinetic interactions.
8                        There are no apparent pharmacokinetic interactions among the drugs.
9 ated treatment regimens designed to minimize pharmacokinetic interactions and to potentiate immunosup
10              For antiepileptic drugs (AEDs), pharmacokinetic interactions are the most notable type,
11                    By far the most important pharmacokinetic interactions are those involving cytochr
12                   Preliminary data showed no pharmacokinetic interaction between A + T.
13                       There is a significant pharmacokinetic interaction between capecitabine and S-w
14 ultaneous dosing, there was no evidence of a pharmacokinetic interaction between CsA and RAD.
15 conducted a phase I/IIa study to investigate pharmacokinetic interaction between IVC and gemcitabine.
16                                    Thus, the pharmacokinetic interaction between oral SRL and CsA con
17                                  There is no pharmacokinetic interaction between paclitaxel and carbo
18 ESLD) (substudy 1) and to assess the lack of pharmacokinetic interaction between RAL and the immunosu
19 ent dose, seems well tolerated, with minimal pharmacokinetic interaction between the two agents.
20               Recent reports indicate that a pharmacokinetic interaction between these two drugs may
21                      There is no evidence of pharmacokinetic interaction between vesnarinone and gemc
22  coinfection; however, little is known about pharmacokinetic interactions between boceprevir and anti
23 A randomized, open-label study to assess the pharmacokinetic interactions between boceprevir and rito
24                                              Pharmacokinetic interactions between chemotherapy and hi
25 nsplant recipients, the authors describe the pharmacokinetic interactions between cyclosporine and th
26                                              Pharmacokinetic interactions between hypothermia and med
27                               No significant pharmacokinetic interactions between leflunomide and met
28                              We investigated pharmacokinetic interactions between PDE-Is (cilostazol
29                                There were no pharmacokinetic interactions between PF-04958242 and ket
30  of data from these trials is complicated by pharmacokinetic interactions between the target cytotoxi
31  suggested that pharmacological, rather than pharmacokinetic, interactions between the parent drugs w
32                                              Pharmacokinetic interactions can involve CYP 2D6, which
33   Detailed mechanistic interrogation of this pharmacokinetic interaction demonstrated that lenalidomi
34                                   Because of pharmacokinetic interactions, drug doses were decreased
35 rsers have in many instances been limited by pharmacokinetic interactions exacerbating the clinical t
36                                    An FA/RIF pharmacokinetic interaction has not previously been desc
37                    Detrimental bidirectional pharmacokinetic interactions have been observed when tel
38        Finally, a general review of possible pharmacokinetic interactions is included to assist the H
39  dose reductions were planned because of the pharmacokinetic interactions known to occur with PSC 833
40 mbination with cyclosporine (CsA) produces a pharmacokinetic interaction, namely increases in the who
41 n of renal dysfunction seemed to be due to a pharmacokinetic interaction of RAPA to greatly increase
42                                         This pharmacokinetic interaction offers a mechanism that may
43                          The effects of this pharmacokinetic interaction on the synergism between SRL
44 udy investigated the efficacy, toxicity, and pharmacokinetic interactions resulting from simultaneous
45                                This two-part pharmacokinetic interaction study evaluated boceprevir w
46 toxicity profile without clinically relevant pharmacokinetic interactions, support the performance of
47 red administration of RAD+Neoral avoided the pharmacokinetic interactions that caused the elevated dr
48                        Except in the case of pharmacokinetic interactions, these toxicities are not d
49                                           No pharmacokinetic interaction was found.
50                                           No pharmacokinetic interaction was observed between cyclosp
51                                           No pharmacokinetic interaction was observed.
52  3-week schedule were well tolerated, and no pharmacokinetic interaction was observed.
53                                              Pharmacokinetic interactions were not responsible for th
54                                           No pharmacokinetic interactions were observed.
55 nticipated toxicities or clinically relevant pharmacokinetic interactions were observed.
56 tes CsA-induced renal dysfunction owing to a pharmacokinetic interaction, whereas CsA produces a phar
57 l of these products participate in potential pharmacokinetic interactions with anticancer drugs.
58                                              Pharmacokinetic interactions with antiretroviral drugs d
59  efficacious modulator that apparently lacks pharmacokinetic interactions with coadministered antican
60 ostazol and sildenafil did not have negative pharmacokinetic interactions with rifampin.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト